AJTMH Tropical Medicine and Hygiene News
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 67(4), 2002, pp. 406-410
Copyright © 2002 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Collins, W.
Right arrow Articles by Jeffery, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Collins, W.
Right arrow Articles by Jeffery, G.
Related Collections
Right arrow Malaria
American Journal of Tropical Medicine and Hygiene, Vol 67, Issue 4, 406-410
Copyright © 2002 by American Society of Tropical Medicine and Hygiene

Research Articles


Extended clearance time after treatment of infections with Plasmodium malariae may not be indicative of resistance to chloroquine

WE Collins and GM Jeffery

A retrospective examination was made of archival data on the response of Plasmodium malariae infections in humans to chloroquine. The clearance time for P. malariae was longer than that for P. falciparum and P. vivax. Of 100 P. malariae-infected patients treated with 1,500 mg of chloroquine given over 3 days, 15 had detectable parasites for 7 days, 4 for 10 days, and 1 for 15 days after treatment. Of 17 patients treated intramuscularly with 450 mg of dihydrochloroquine, parasites persisted in 1 patient for 11 days. Of patients with chloroquine-sensitive P. falciparum. 44 cleared parasites by 6 days after treatment; 37 patients with P. vivax infections cleared parasites by day 5. The confirmation of chloroquine resistance may depend on the adaptation of isolates to nonhuman primates in which controlled drug trials can be made.


This article has been cited by other articles:


Home page
 Am J Trop Med HygHome page
C. Barnadas, A. Ratsimbasoa, H. Ranaivosoa, D. Ralaizandry, D. Raveloariseheno, V. Rabekotonorina, S. Picot, and D. Menard
Prevalence and Chloroquine Sensitivity of Plasmodium malariae in Madagascar
Am J Trop Med Hyg, December 1, 2007; 77(6): 1039 - 1042.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. K. Baird
Effectiveness of Antimalarial Drugs
N. Engl. J. Med., April 14, 2005; 352(15): 1565 - 1577.
[Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
A. O. Talisuna, P. Bloland, and U. D'Alessandro
History, Dynamics, and Public Health Importance of Malaria Parasite Resistance
Clin. Microbiol. Rev., January 1, 2004; 17(1): 235 - 254.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Society of Tropical Medicine and Hygiene.